IOL Chemicals and Pharmaceuticals Limited has informed the Exchange regarding 'Intimation pursuant to Regulation 36(1)(b) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 '.
IOLCP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
IOL Chemicals and Pharmaceuticals has informed the exchanges that it has sent letters to shareholders whose email addresses are not registered, providing them the weblink to access the Integrated Annual Report for FY 2024-25, in line with SEBI's Listing Regulations 36(1)(b). The company's 38th Annual General Meeting (AGM) is scheduled for Friday, 22nd August 2025 at 11:30 AM (IST), to be held via Video Conferencing / Other Audio-Visual Means. The AGM Notice and Annual Report are available on the company's website (www.iolcp.com), as well as on BSE, NSE, and CDSL's evoting portal. Shareholders in physical mode or without updated emails are requested to register their email with the Registrar (Alankit Assignments Ltd.) or their Depository Participants.
This is a routine regulatory compliance filing ahead of the AGM and does not carry any direct impact on share price or shareholder value. Investors can now review the FY 2024-25 annual report for performance details and the AGM agenda through the provided weblink.